Clinical Trial Update: A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K [Phase 3]

View source ↗

Summary

Astellas reports a Phase 3 continuation study of ASP015K for rheumatoid arthritis patients who completed prior Phase IIb or Phase III trials. The results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2020-10-23